The Assistance Fund (TAF)
Gerald Lauria has extensive experience in the pharmaceutical industry, with a strong background in business development, advocacy, and sales. Gerald is currently serving as the Chief Development Officer at The Assistance Fund (TAF), where they previously held the position of Vice President of Business Development and Strategy. Prior to their time at TAF, Gerald worked as the Director of Business Development and Advocacy for the company. Before joining TAF, they worked at AstraZeneca as a District Business Manager and at Sunovion Pharmaceuticals Inc. in various management and sales roles, including Leadership Development Manager, District Manager, Institutional Sales Specialist, Regional Therapeutic Specialist, and Pharmaceutical Sales Specialist. Gerald also has experience as a Senior Pharmaceutical Consultant at GlaxoSmithKline.
Gerald Lauria holds a Bachelor of Arts (B.A.) degree from Rutgers University. No further information is available regarding their educational timeline or field of study.
This person is not in any offices
The Assistance Fund (TAF)
1 followers
The Assistance Fund (TAF) is an independent charitable patient assistance organization that helps patients and families facing high medical out-of-pocket costs by providing financial assistance for their copayments, coinsurance, deductibles, and other health-related expenses. We currently manage nearly 90 disease programs, each of which covers all FDA-approved treatment for the disease named in the program. Since 2009, TAF has helped nearly 180,000 people access critical treatment for life-threatening, chronic, and rare diseases. TAF's MISSION is to provide underinsured people living with life-threatening, chronic, and rare diseases access to critical treatment through financial assistance, education, and advocacy. TAF's VISION is to see the day when no person goes without treatment because of an inability to pay.